Microfluidic-Based Multi-Organ Platforms for Drug Discovery

Development of predictive multi-organ models before implementing costly clinical trials is central for screening the toxicity, efficacy, and side effects of new therapeutic agents. Despite significant efforts that have been recently made to develop biomimetic in vitro tissue models, the clinical app...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezaei Kolahchi, Ahmad, Khadem Mohtaram, Nima, Pezeshgi Modarres, Hassan, Mohammadi, Mohammad Hossein, Geraili, Armin, Jafari, Parya, Akbari, Mohsen, Sanati-Nezhad, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189912/
https://www.ncbi.nlm.nih.gov/pubmed/30404334
http://dx.doi.org/10.3390/mi7090162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189912/
https://www.ncbi.nlm.nih.gov/pubmed/30404334
http://dx.doi.org/10.3390/mi7090162

Ejemplares similares